Source: Virtual Congress 2021 – Health effects of tobacco and medical professionals



Rating:

Share or cite this content

Citations should be made in the following way:
K. Kchaou (Ariana, Tunisia), A. Ben Ayed (Ariana, Tunisia), A. Chaker (Ariana, Tunisia), S. Khaldi (Ariana, Tunisia), S. Mokaddem (Ariana, Tunisia), S. Jameleddine (Ariana, Tunisia). Impact of Cardiovascular Disease on dyspnea and lung function in a population of Tunisian smokers without airflow limitation. 2444

Member's Comments

No comment yet.

Related content which might interest you: The importance of dyspnea and airflow limitation for anxiety and depression in COPD Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Case-finding options for COPD: results from the Burden of Obstructive Lung Disease Study Source: Eur Respir J 2013; 41: 548-555 Year: 2013 Severity of airway obstruction in overweight/obese patients with chronic obstructive pulmonary disease(COPD) Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Obstructive sleep apnea accelerates decline in FEV1 in asthmatic patients Source: International Congress 2014 – Direct and indirect monitoring of comorbidities Year: 2014 The population risk attribution associated with chronic airway obstruction from the results of the Canadian Obstructive Lung Disease study. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Breathlessness perception in COPD: Relationship with exacerbation frequency Source: International Congress 2015 – Multidimensional analysis of respiratory problems Year: 2015 Physical activity and symptom burden in COPD: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021 Association between airflow limitation severity and comorbidities in Japanese men Source: Virtual Congress 2020 – Risk factors for chronic lung diseases Year: 2020 Determinants of severity of dyspnea in COPD Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Determinants of dyspnea in COPD patients: the French PALOMB cohort Source: International Congress 2018 – COPD around the world Year: 2018 Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Cardiovascular limitation to exercise in COPD patients Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Determinants for the reversibility of airflow limitation in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 289s Year: 2005 Airflow limitation and airway inflammation of asthmatic adolescents in remission Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016 High prevalence of undiagnosed airflow obstruction in patients with ischaemic heart disease Source: International Congress 2014 – Direct and indirect monitoring of comorbidities Year: 2014 Ventilation inhomogeneity in children with severe asthma and normal spirometry indicates residual airways disease Source: Annual Congress 2013 –Clinical applications of respiratory physiology in children Year: 2013 Comorbidities impair physical activity in COPD irrespective of airflow limitation Source: International Congress 2014 – Comorbidities Year: 2014 Impacts of bronchiectasis in asthma patients with airflow limitation Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Impact of airflow obstruction severity on the course of COPD during follow-up Source: International Congress 2014 – Lung function testing: new findings and new approaches Year: 2014 Cardiac structure and function at baseline in the DEFLATA study: The impact of lung hyperinflation and its relationship with the GOLD classification Source: International Congress 2014 – The assessment of comorbidities Year: 2014